ECSP951438A - Azithromycin Controlled Release Dosage Forms - Google Patents
Azithromycin Controlled Release Dosage FormsInfo
- Publication number
- ECSP951438A ECSP951438A ECSP951438A ECSP951438A EC SP951438 A ECSP951438 A EC SP951438A EC SP951438 A ECSP951438 A EC SP951438A EC SP951438 A ECSP951438 A EC SP951438A
- Authority
- EC
- Ecuador
- Prior art keywords
- controlled release
- release dosage
- azithromycin
- dosage forms
- dosage form
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 4
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title abstract 3
- 229960004099 azithromycin Drugs 0.000 title abstract 3
- 238000013270 controlled release Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El invento se refiere a una forma de dosificación de liberación controlada de azitromicina que tiene un perfil de efectos secundarios mejorado; un procedimiento para la preparación de la forma de dosificación, y un procedimiento de tratamiento de infección microbiana que comprende la administración de azitromicina en dicha forma de dosificación de liberación controlada a un mamífero, incluyendo a un humano, en necesidades de dicho tratamiento.The invention relates to a controlled release dosage form of azithromycin having an improved side effect profile; a method of preparing the dosage form, and a method of treating microbial infection comprising administering azithromycin in said controlled release dosage form to a mammal, including a human, in need of such treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP951438 ECSP951438A (en) | 1995-05-05 | 1995-05-05 | Azithromycin Controlled Release Dosage Forms |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP951438 ECSP951438A (en) | 1995-05-05 | 1995-05-05 | Azithromycin Controlled Release Dosage Forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP951438A true ECSP951438A (en) | 1996-05-10 |
Family
ID=42042083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP951438 ECSP951438A (en) | 1995-05-05 | 1995-05-05 | Azithromycin Controlled Release Dosage Forms |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP951438A (en) |
-
1995
- 1995-05-05 EC ECSP951438 patent/ECSP951438A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4290346A1 (en) | Azithromycin Controlled Release Dosage Forms | |
| IL130931A0 (en) | Small molecules useful in the treatment of inflammatory disease | |
| SV1995000007A (en) | DERIVATIVES OF 5-SUBSTITUTED MYCOPHENOLIC ACID. | |
| ECSP105739A (en) | NEUTRALIZATION ANTIBODIES AGAINST GDF-8 | |
| BR9502707A (en) | Compound pharmaceutical composition and method for treating a condition | |
| FI956014A0 (en) | Use of non- and decapeptides in the manufacture of a medicament for the treatment of AIDS | |
| AR034746A1 (en) | COMBINATIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | |
| DE60121988D1 (en) | COMBINATION THERAPY WITH ANTIDIBLE AND ANTICONVULSIVE AGENTS | |
| MX9701385A (en) | Combined preparation for the therapy of immune diseases. | |
| MY138883A (en) | Use of asiatic acid for treatment of cencer | |
| PT1173201E (en) | METHOD FOR THE TREATMENT OF FIBROSIS USING AN ALTAGONIST OF THE ALPHA 4 SUBSTANCE OF INTEGRINA | |
| BR0107628A (en) | 1,2-diarylbenzimidazoles for treating diseases that are associated with microglial activation | |
| EP0869801A4 (en) | THERAPEUTIC AND DIAGNOSTIC AGENTS FOR TREATING MICROBIAL INFECTIONS | |
| NZ510153A (en) | Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals | |
| DK1237562T3 (en) | Process for the preparation of micania extracts containing micanolide and dihydromycanolide and use in the treatment of proliferative diseases | |
| AR029451A1 (en) | A COMPOSITION FOR USE IN THE BREAST CANCER THERAPY IN HUMAN BEINGS AND A PRODUCT FOR USE IN SUCH THERAPY | |
| ECSP951438A (en) | Azithromycin Controlled Release Dosage Forms | |
| GT199500023A (en) | DOSAGE FORMS OF CONTROLLED RELEASE AZITHROMYCIN | |
| PT1052991E (en) | USING LOPERAMID FOR THE TREATMENT OF MICROBIAL INFECTIONS | |
| BR9708037A (en) | Method for the treatment of substance abuse | |
| ES1034986Y (en) | APPARATUS FOR THE TREATMENT OF THE HUMAN BODY. | |
| ECSP951424A (en) | PROCEDURE FOR THE ADMINISTRATION OF AZYTHROMYCIN | |
| BR9612549A (en) | Method for treating excessive aggression | |
| TR200100043T2 (en) | Derivatives of tetra hydropyridine (or 4-Hydroxypipeidine) -butylosolines in the preparation of drugs in the treatment of pain | |
| CO5170459A1 (en) | TRANSDERMAL THERAPY WITH LON-OL STROGEN AGONISTS-ANTAGONISTS, ADMINISTERED BY TRANSDERMAL MEDIA |